Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2018 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Imatinib-induced bone edema: case report and review of literature.
dos Santos LV, Lima JP, Abdalla KC, Bragagnoli AC, Santos FA, dos Anjos Jácome A, Porto FE. dos Santos LV, et al. Among authors: abdalla kc. J Natl Compr Canc Netw. 2013 Oct 1;11(10):1187-91. doi: 10.6004/jnccn.2013.0140. J Natl Compr Canc Netw. 2013. PMID: 24142819 Review.
Timing of adjuvant chemotherapy in colorectal cancer.
Dos Santos LV, Faria TM, Lima AB, Abdalla KC, de Moraes ED, Cruz MR, Lima JP. Dos Santos LV, et al. Among authors: abdalla kc. Colorectal Dis. 2016 Sep;18(9):871-6. doi: 10.1111/codi.13306. Colorectal Dis. 2016. PMID: 26900665
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial.
Bragagnoli AC, Araujo RLC, Ferraz MW, Dos Santos LV, Abdalla KC, Comar F, Santos FA, Oliveira MA, Carvalheira JBC, Cárcano FM, da Silveira Nogueira Lima JP. Bragagnoli AC, et al. Among authors: abdalla kc. Br J Cancer. 2021 Mar;124(6):1072-1078. doi: 10.1038/s41416-020-01208-6. Epub 2021 Jan 4. Br J Cancer. 2021. PMID: 33398062 Free PMC article. Clinical Trial.
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
Romera A, Peredpaya S, Shparyk Y, Bondarenko I, Mendonça Bariani G, Abdalla KC, Roca E, Franke F, Melo Cruz F, Ramesh A, Ostwal V, Shah P, Rahuman SA, Paravisini A, Huerga C, Del Campo García A, Millán S. Romera A, et al. Among authors: abdalla kc. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):845-855. doi: 10.1016/S2468-1253(18)30269-3. Epub 2018 Sep 24. Lancet Gastroenterol Hepatol. 2018. PMID: 30262136 Clinical Trial.